ISO Regulatory Requirements for Medical Devices

Key ISO standards applicable to medical device development, quality management, and regulatory compliance.

tools-only Updated Sep 29, 2026 7 repo stars

Coding & Dev Tools

Install

Press C to copy

$ npx skillmds@latest add tools-only/iso-regulatory-requirements-for-medical-devices

Installs into ~/.claude/skills (or .claude/skills inside a project). Restart Claude Code to pick it up.

＋ Add to plugin

README badge

[![SkillMD](https://skillmd.com/badge/tools-only/iso-regulatory-requirements-for-medical-devices.svg)](https://skillmd.com/skills/tools-only/iso-regulatory-requirements-for-medical-devices)

Trust & safety

2 of 3 audits passed

Last audited Sep 23, 2026 · commit 30dc8bb

Works with: Claude Code Claude.ai OpenAI Codex +

File contents

ISO Regulatory Requirements for Medical Devices

Key ISO standards applicable to medical device development, quality management, and regulatory compliance.

Table of Contents

ISO 13485 Quality Management
ISO 14971 Risk Management
ISO 10993 Biocompatibility
IEC 62304 Software Lifecycle
IEC 62366 Usability Engineering
ISO 11607 Packaging Validation
Sterilization Standards
Standards Cross-Reference

ISO 13485 Quality Management

ISO 13485:2016 Overview

Aspect	Requirement
Scope	QMS for design, development, production, installation, and servicing
Certification	Third-party certification required for most markets
Regulatory Status	Harmonized under EU MDR; recognized by FDA QSIT
Validity	3-year certification cycle with annual surveillance

Key Clause Requirements

Clause	Title	Regulatory Focus
4.1	General Requirements	Process-based QMS, outsourcing control
4.2	Documentation	Quality Manual, procedures, records
5.1-5.6	Management Responsibility	Policy, planning, review
6.1-6.4	Resource Management	Competence, infrastructure, environment
7.1	Planning	Risk management integration
7.2	Customer-Related	Requirements determination and review
7.3	Design and Development	Design controls (critical for FDA)
7.4	Purchasing	Supplier controls
7.5	Production	Process validation, identification, traceability
7.6	Monitoring Equipment	Calibration
8.2	Monitoring	Feedback, complaints, audits
8.3	Nonconforming Product	Control and disposition
8.5	Improvement	CAPA

Design Control Requirements (Clause 7.3)

Stage	Clause	Deliverables
Planning	7.3.2	Design plan, stages, responsibilities
Inputs	7.3.3	Requirements specification
Outputs	7.3.4	Design specifications, acceptance criteria
Review	7.3.5	Design review records
Verification	7.3.6	Verification testing reports
Validation	7.3.7	Validation protocols and reports
Transfer	7.3.8	Transfer verification records
Changes	7.3.9	Change control records

Regulatory Mapping

Regulation	ISO 13485 Recognition
EU MDR 2017/745	Harmonized standard (presumption of conformity)
FDA 21 CFR 820	Substantially equivalent; QSIT alignment
Health Canada	MDSAP or direct recognition
PMDA Japan	Recognized with MHLW certification
TGA Australia	Accepted as conformity evidence
ANVISA Brazil	Required for GMP compliance

ISO 14971 Risk Management

ISO 14971:2019 Overview

Aspect	Requirement
Scope	Risk management throughout medical device lifecycle
Regulatory Status	Harmonized under EU MDR; referenced by FDA
Key Change (2019)	Enhanced benefit-risk analysis emphasis
Documentation	Risk management file required

Risk Management Process

Stage	Activities	Outputs
Planning	Define scope, responsibilities, criteria	Risk management plan
Risk Analysis	Identify hazards, estimate risk	Hazard analysis, risk estimation
Risk Evaluation	Compare against acceptability criteria	Risk evaluation records
Risk Control	Select and implement controls	Risk control measures
Residual Risk	Evaluate remaining risk	Residual risk evaluation
Risk-Benefit	Assess overall benefit-risk	Benefit-risk analysis
Review	Periodic risk management review	Risk management report

Risk Analysis Methods

Method	Application	Standard Reference
FMEA	Component/process failure modes	IEC 60812
FTA	System-level failure analysis	IEC 61025
HAZOP	Process hazard identification	IEC 61882
PHA	Preliminary hazard assessment	-

Risk Acceptability Matrix

Severity	Probability	Risk Level	Action
Catastrophic	Frequent	Unacceptable	Design change required
Critical	Probable	ALARP	Risk reduction required
Serious	Occasional	ALARP	Risk reduction if practicable
Minor	Remote	Acceptable	Monitor
Negligible	Improbable	Acceptable	Document

Post-Production Risk Management

Activity	Frequency	Sources
Complaint Analysis	Continuous	Customer complaints
Vigilance Review	Continuous	Adverse event reports
Literature Review	Annual	Scientific publications
Standards Review	Annual	Updated standards
Risk File Update	As needed	New information

ISO 10993 Biocompatibility

ISO 10993-1:2018 Biological Evaluation Framework

Contact Type	Duration	Required Tests
Surface - Skin	Limited (<24h)	Cytotoxicity, sensitization, irritation
Surface - Mucosal	Prolonged (24h-30d)	+ Acute systemic toxicity
Surface - Breached	Permanent (>30d)	+ Subchronic toxicity, genotoxicity
External Communicating	Limited	Cytotoxicity, sensitization, irritation, hemolysis
External Communicating	Prolonged	+ Subchronic toxicity, implantation
External Communicating	Permanent	+ Chronic toxicity, carcinogenicity
Implant	Limited	Full biological evaluation
Implant	Prolonged/Permanent	Comprehensive testing including implantation

Key Test Standards

Standard	Test
ISO 10993-3	Genotoxicity, carcinogenicity, reproductive toxicity
ISO 10993-4	Hemocompatibility
ISO 10993-5	Cytotoxicity (in vitro)
ISO 10993-6	Local effects after implantation
ISO 10993-10	Irritation and skin sensitization
ISO 10993-11	Systemic toxicity
ISO 10993-12	Sample preparation and reference materials
ISO 10993-18	Chemical characterization

Biocompatibility Evaluation Workflow

Define device contact nature and duration
Identify materials in contact with body
Perform chemical characterization (ISO 10993-18)
Conduct gap analysis against required endpoints
Plan and execute required testing
Document biological evaluation report
Update for material or design changes
Validation: All endpoints addressed; testing per GLP; BE report complete

IEC 62304 Software Lifecycle

IEC 62304:2006/AMD1:2015 Overview

Aspect	Requirement
Scope	Medical device software development lifecycle
Regulatory Status	Harmonized under EU MDR; FDA guidance reference
Key Concept	Safety classification drives rigor
Documentation	Software development plan, architecture, testing

Software Safety Classification

Class	Definition	Documentation Rigor
A	No injury or damage possible	Basic
B	Non-serious injury possible	Moderate
C	Death or serious injury possible	High

Required Processes by Class

Process	Class A	Class B	Class C
Software Development Planning	Required	Required	Required
Software Requirements Analysis	Required	Required	Required
Software Architecture Design	-	Required	Required
Software Detailed Design	-	-	Required
Software Unit Implementation	Required	Required	Required
Software Unit Verification	-	Required	Required
Software Integration Testing	Required	Required	Required
Software System Testing	Required	Required	Required
Software Release	Required	Required	Required
Software Maintenance	Required	Required	Required
Software Risk Management	Required	Required	Required
Software Configuration Management	Required	Required	Required
Software Problem Resolution	Required	Required	Required

Documentation Requirements

Document	Class A	Class B	Class C
Software Development Plan	✓	✓	✓
Software Requirements Specification	✓	✓	✓
Software Architecture Document	-	✓	✓
Software Detailed Design	-	-	✓
Software Unit Test Records	-	✓	✓
Integration Test Records	✓	✓	✓
System Test Records	✓	✓	✓
Traceability Matrix	-	✓	✓

IEC 62366 Usability Engineering

IEC 62366-1:2015 Overview

Aspect	Requirement
Scope	Usability engineering process for medical devices
Regulatory Status	Harmonized under EU MDR; FDA HFE guidance
Key Concept	Use-related risk identification and mitigation
Documentation	Usability engineering file

Usability Engineering Process

Stage	Activities	Outputs
Use Specification	Define users, use environments, user interface	Use specification document
User Interface Design	Design UI with task analysis input	UI specifications
Hazard Analysis	Identify use-related hazards	Use-related risk analysis
Formative Evaluation	Iterative design testing	Formative evaluation reports
Summative Evaluation	Final design validation	Summative evaluation report
Documentation	Compile usability engineering file	UEF

Usability Testing Requirements

Test Type	Purpose	Participants
Formative	Identify usability issues during design	Representative users (5-8 per iteration)
Summative	Validate final design	Representative users (15+ per user group)
Simulated Use	Test under realistic conditions	Trained users in simulated environment
Actual Use	Validate in clinical setting	Actual users in actual environment

Usability Engineering File Contents

Section	Content
Use Specification	User profiles, use environments, user interface
Use-Related Risk Analysis	Hazard identification, risk evaluation
UI Design Specifications	Design requirements, rationale
Formative Evaluation	Test protocols, results, design changes
Summative Evaluation	Validation protocol, results, conclusions
Residual Risk	Remaining use-related risks

ISO 11607 Packaging Validation

ISO 11607-1:2019 and ISO 11607-2:2019

Part	Scope
Part 1	Requirements for materials, sterile barrier systems, packaging systems
Part 2	Validation requirements for forming, sealing, and assembly processes

Packaging Validation Stages

Stage	Activities	Documentation
IQ	Equipment installation verification	Installation records
OQ	Process parameter verification	OQ protocol and report
PQ	Performance under production conditions	PQ protocol and report

Required Testing

Test	Standard	Purpose
Seal Strength	ASTM F88	Peel strength measurement
Seal Integrity	ASTM F2095	Bubble leak test
Visual Inspection	ISO 11607-1	Defect identification
Package Integrity	ASTM D4169	Distribution simulation
Accelerated Aging	ASTM F1980	Shelf life validation
Real-Time Aging	-	Stability confirmation

Shelf Life Validation

Method	Approach	Considerations
Accelerated Aging	Q10 = 2 (typically)	Per ASTM F1980
Real-Time Aging	Concurrent with accelerated	Required for final claim
Worst-Case Testing	Post-aging integrity testing	Distribution + storage conditions

Sterilization Standards

Common Sterilization Methods

Method	Standard	Applications
EO (Ethylene Oxide)	ISO 11135:2014	Heat/moisture sensitive
Steam	ISO 17665-1:2006	Heat/moisture tolerant
Radiation	ISO 11137:2017	Heat sensitive, high volume
Dry Heat	ISO 20857:2010	Moisture sensitive
Aseptic Processing	ISO 13408	Prefilled syringes

Sterilization Validation Requirements

Phase	Activities	Documentation
IQ	Equipment installation	Installation records
OQ	Process parameter qualification	OQ protocol and report
PQ	Microbiological performance	Bioburden, SAL demonstration
Routine Control	Process monitoring	Batch records, BI results

Sterility Assurance Level (SAL)

SAL	Probability of Non-Sterile	Application
10⁻⁶	1 in 1 million	Most medical devices
10⁻³	1 in 1,000	Aseptically processed

Standards Cross-Reference

Regulatory Alignment

Standard	EU MDR	FDA	Health Canada	TGA
ISO 13485	Harmonized	Recognized	Required	Accepted
ISO 14971	Harmonized	Referenced	Required	Accepted
ISO 10993	Harmonized	Referenced	Required	Accepted
IEC 62304	Harmonized	Referenced	Required	Accepted
IEC 62366	Harmonized	Referenced	Required	Accepted

Version Requirements

Standard	Current Version	Transition Deadline
ISO 13485	2016	Active
ISO 14971	2019	Active
ISO 10993-1	2018	Active
IEC 62304	2006/Amd1:2015	Active
IEC 62366-1	2015/Amd1:2020	Active

Certification Bodies

Region	Certification Body Type
EU	Notified Bodies (per MDR)
USA	FDA-recognized accreditation bodies
MDSAP	Authorized auditing organizations
Global	ISO certification bodies (IATF, DNV, BSI, TÜV)

---name: iso-regulatory-requirements-for-medical-devicesdescription: Key ISO standards applicable to medical device development, quality management, and regulatory compliance.---# ISO Regulatory Requirements for Medical DevicesKey ISO standards applicable to medical device development, quality management, and regulatory compliance.---## Table of Contents- [ISO 13485 Quality Management](#iso-13485-quality-management)- [ISO 14971 Risk Management](#iso-14971-risk-management)- [ISO 10993 Biocompatibility](#iso-10993-biocompatibility)- [IEC 62304 Software Lifecycle](#iec-62304-software-lifecycle)- [IEC 62366 Usability Engineering](#iec-62366-usability-engineering)- [ISO 11607 Packaging Validation](#iso-11607-packaging-validation)- [Sterilization Standards](#sterilization-standards)- [Standards Cross-Reference](#standards-cross-reference)---## ISO 13485 Quality Management### ISO 13485:2016 Overview| Aspect | Requirement ||--------|-------------|| Scope | QMS for design, development, production, installation, and servicing || Certification | Third-party certification required for most markets || Regulatory Status | Harmonized under EU MDR; recognized by FDA QSIT || Validity | 3-year certification cycle with annual surveillance |### Key Clause Requirements| Clause | Title | Regulatory Focus ||--------|-------|------------------|| 4.1 | General Requirements | Process-based QMS, outsourcing control || 4.2 | Documentation | Quality Manual, procedures, records || 5.1-5.6 | Management Responsibility | Policy, planning, review || 6.1-6.4 | Resource Management | Competence, infrastructure, environment || 7.1 | Planning | Risk management integration || 7.2 | Customer-Related | Requirements determination and review || 7.3 | Design and Development | Design controls (critical for FDA) || 7.4 | Purchasing | Supplier controls || 7.5 | Production | Process validation, identification, traceability || 7.6 | Monitoring Equipment | Calibration || 8.2 | Monitoring | Feedback, complaints, audits || 8.3 | Nonconforming Product | Control and disposition || 8.5 | Improvement | CAPA |### Design Control Requirements (Clause 7.3)| Stage | Clause | Deliverables ||-------|--------|--------------|| Planning | 7.3.2 | Design plan, stages, responsibilities || Inputs | 7.3.3 | Requirements specification || Outputs | 7.3.4 | Design specifications, acceptance criteria || Review | 7.3.5 | Design review records || Verification | 7.3.6 | Verification testing reports || Validation | 7.3.7 | Validation protocols and reports || Transfer | 7.3.8 | Transfer verification records || Changes | 7.3.9 | Change control records |### Regulatory Mapping| Regulation | ISO 13485 Recognition ||------------|----------------------|| EU MDR 2017/745 | Harmonized standard (presumption of conformity) || FDA 21 CFR 820 | Substantially equivalent; QSIT alignment || Health Canada | MDSAP or direct recognition || PMDA Japan | Recognized with MHLW certification || TGA Australia | Accepted as conformity evidence || ANVISA Brazil | Required for GMP compliance |---## ISO 14971 Risk Management### ISO 14971:2019 Overview| Aspect | Requirement ||--------|-------------|| Scope | Risk management throughout medical device lifecycle || Regulatory Status | Harmonized under EU MDR; referenced by FDA || Key Change (2019) | Enhanced benefit-risk analysis emphasis || Documentation | Risk management file required |### Risk Management Process| Stage | Activities | Outputs ||-------|------------|---------|| Planning | Define scope, responsibilities, criteria | Risk management plan || Risk Analysis | Identify hazards, estimate risk | Hazard analysis, risk estimation || Risk Evaluation | Compare against acceptability criteria | Risk evaluation records || Risk Control | Select and implement controls | Risk control measures || Residual Risk | Evaluate remaining risk | Residual risk evaluation || Risk-Benefit | Assess overall benefit-risk | Benefit-risk analysis || Review | Periodic risk management review | Risk management report |### Risk Analysis Methods| Method | Application | Standard Reference ||--------|-------------|-------------------|| FMEA | Component/process failure modes | IEC 60812 || FTA | System-level failure analysis | IEC 61025 || HAZOP | Process hazard identification | IEC 61882 || PHA | Preliminary hazard assessment | - |### Risk Acceptability Matrix| Severity | Probability | Risk Level | Action ||----------|-------------|------------|--------|| Catastrophic | Frequent | Unacceptable | Design change required || Critical | Probable | ALARP | Risk reduction required || Serious | Occasional | ALARP | Risk reduction if practicable || Minor | Remote | Acceptable | Monitor || Negligible | Improbable | Acceptable | Document |### Post-Production Risk Management| Activity | Frequency | Sources ||----------|-----------|---------|| Complaint Analysis | Continuous | Customer complaints || Vigilance Review | Continuous | Adverse event reports || Literature Review | Annual | Scientific publications || Standards Review | Annual | Updated standards || Risk File Update | As needed | New information |---## ISO 10993 Biocompatibility### ISO 10993-1:2018 Biological Evaluation Framework| Contact Type | Duration | Required Tests ||--------------|----------|----------------|| Surface - Skin | Limited (<24h) | Cytotoxicity, sensitization, irritation || Surface - Mucosal | Prolonged (24h-30d) | + Acute systemic toxicity || Surface - Breached | Permanent (>30d) | + Subchronic toxicity, genotoxicity || External Communicating | Limited | Cytotoxicity, sensitization, irritation, hemolysis || External Communicating | Prolonged | + Subchronic toxicity, implantation || External Communicating | Permanent | + Chronic toxicity, carcinogenicity || Implant | Limited | Full biological evaluation || Implant | Prolonged/Permanent | Comprehensive testing including implantation |### Key Test Standards| Standard | Test ||----------|------|| ISO 10993-3 | Genotoxicity, carcinogenicity, reproductive toxicity || ISO 10993-4 | Hemocompatibility || ISO 10993-5 | Cytotoxicity (in vitro) || ISO 10993-6 | Local effects after implantation || ISO 10993-10 | Irritation and skin sensitization || ISO 10993-11 | Systemic toxicity || ISO 10993-12 | Sample preparation and reference materials || ISO 10993-18 | Chemical characterization |### Biocompatibility Evaluation Workflow1. Define device contact nature and duration2. Identify materials in contact with body3. Perform chemical characterization (ISO 10993-18)4. Conduct gap analysis against required endpoints5. Plan and execute required testing6. Document biological evaluation report7. Update for material or design changes8. **Validation:** All endpoints addressed; testing per GLP; BE report complete---## IEC 62304 Software Lifecycle### IEC 62304:2006/AMD1:2015 Overview| Aspect | Requirement ||--------|-------------|| Scope | Medical device software development lifecycle || Regulatory Status | Harmonized under EU MDR; FDA guidance reference || Key Concept | Safety classification drives rigor || Documentation | Software development plan, architecture, testing |### Software Safety Classification| Class | Definition | Documentation Rigor ||-------|------------|---------------------|| A | No injury or damage possible | Basic || B | Non-serious injury possible | Moderate || C | Death or serious injury possible | High |### Required Processes by Class| Process | Class A | Class B | Class C ||---------|---------|---------|---------|| Software Development Planning | Required | Required | Required || Software Requirements Analysis | Required | Required | Required || Software Architecture Design | - | Required | Required || Software Detailed Design | - | - | Required || Software Unit Implementation | Required | Required | Required || Software Unit Verification | - | Required | Required || Software Integration Testing | Required | Required | Required || Software System Testing | Required | Required | Required || Software Release | Required | Required | Required || Software Maintenance | Required | Required | Required || Software Risk Management | Required | Required | Required || Software Configuration Management | Required | Required | Required || Software Problem Resolution | Required | Required | Required |### Documentation Requirements| Document | Class A | Class B | Class C ||----------|---------|---------|---------|| Software Development Plan | ✓ | ✓ | ✓ || Software Requirements Specification | ✓ | ✓ | ✓ || Software Architecture Document | - | ✓ | ✓ || Software Detailed Design | - | - | ✓ || Software Unit Test Records | - | ✓ | ✓ || Integration Test Records | ✓ | ✓ | ✓ || System Test Records | ✓ | ✓ | ✓ || Traceability Matrix | - | ✓ | ✓ |---## IEC 62366 Usability Engineering### IEC 62366-1:2015 Overview| Aspect | Requirement ||--------|-------------|| Scope | Usability engineering process for medical devices || Regulatory Status | Harmonized under EU MDR; FDA HFE guidance || Key Concept | Use-related risk identification and mitigation || Documentation | Usability engineering file |### Usability Engineering Process| Stage | Activities | Outputs ||-------|------------|---------|| Use Specification | Define users, use environments, user interface | Use specification document || User Interface Design | Design UI with task analysis input | UI specifications || Hazard Analysis | Identify use-related hazards | Use-related risk analysis || Formative Evaluation | Iterative design testing | Formative evaluation reports || Summative Evaluation | Final design validation | Summative evaluation report || Documentation | Compile usability engineering file | UEF |### Usability Testing Requirements| Test Type | Purpose | Participants ||-----------|---------|--------------|| Formative | Identify usability issues during design | Representative users (5-8 per iteration) || Summative | Validate final design | Representative users (15+ per user group) || Simulated Use | Test under realistic conditions | Trained users in simulated environment || Actual Use | Validate in clinical setting | Actual users in actual environment |### Usability Engineering File Contents| Section | Content ||---------|---------|| Use Specification | User profiles, use environments, user interface || Use-Related Risk Analysis | Hazard identification, risk evaluation || UI Design Specifications | Design requirements, rationale || Formative Evaluation | Test protocols, results, design changes || Summative Evaluation | Validation protocol, results, conclusions || Residual Risk | Remaining use-related risks |---## ISO 11607 Packaging Validation### ISO 11607-1:2019 and ISO 11607-2:2019| Part | Scope ||------|-------|| Part 1 | Requirements for materials, sterile barrier systems, packaging systems || Part 2 | Validation requirements for forming, sealing, and assembly processes |### Packaging Validation Stages| Stage | Activities | Documentation ||-------|------------|---------------|| IQ | Equipment installation verification | Installation records || OQ | Process parameter verification | OQ protocol and report || PQ | Performance under production conditions | PQ protocol and report |### Required Testing| Test | Standard | Purpose ||------|----------|---------|| Seal Strength | ASTM F88 | Peel strength measurement || Seal Integrity | ASTM F2095 | Bubble leak test || Visual Inspection | ISO 11607-1 | Defect identification || Package Integrity | ASTM D4169 | Distribution simulation || Accelerated Aging | ASTM F1980 | Shelf life validation || Real-Time Aging | - | Stability confirmation |### Shelf Life Validation| Method | Approach | Considerations ||--------|----------|----------------|| Accelerated Aging | Q10 = 2 (typically) | Per ASTM F1980 || Real-Time Aging | Concurrent with accelerated | Required for final claim || Worst-Case Testing | Post-aging integrity testing | Distribution + storage conditions |---## Sterilization Standards### Common Sterilization Methods| Method | Standard | Applications ||--------|----------|--------------|| EO (Ethylene Oxide) | ISO 11135:2014 | Heat/moisture sensitive || Steam | ISO 17665-1:2006 | Heat/moisture tolerant || Radiation | ISO 11137:2017 | Heat sensitive, high volume || Dry Heat | ISO 20857:2010 | Moisture sensitive || Aseptic Processing | ISO 13408 | Prefilled syringes |### Sterilization Validation Requirements| Phase | Activities | Documentation ||-------|------------|---------------|| IQ | Equipment installation | Installation records || OQ | Process parameter qualification | OQ protocol and report || PQ | Microbiological performance | Bioburden, SAL demonstration || Routine Control | Process monitoring | Batch records, BI results |### Sterility Assurance Level (SAL)| SAL | Probability of Non-Sterile | Application ||-----|----------------------------|-------------|| 10⁻⁶ | 1 in 1 million | Most medical devices || 10⁻³ | 1 in 1,000 | Aseptically processed |---## Standards Cross-Reference### Regulatory Alignment| Standard | EU MDR | FDA | Health Canada | TGA ||----------|--------|-----|---------------|-----|| ISO 13485 | Harmonized | Recognized | Required | Accepted || ISO 14971 | Harmonized | Referenced | Required | Accepted || ISO 10993 | Harmonized | Referenced | Required | Accepted || IEC 62304 | Harmonized | Referenced | Required | Accepted || IEC 62366 | Harmonized | Referenced | Required | Accepted |### Version Requirements| Standard | Current Version | Transition Deadline ||----------|-----------------|---------------------|| ISO 13485 | 2016 | Active || ISO 14971 | 2019 | Active || ISO 10993-1 | 2018 | Active || IEC 62304 | 2006/Amd1:2015 | Active || IEC 62366-1 | 2015/Amd1:2020 | Active |### Certification Bodies| Region | Certification Body Type ||--------|------------------------|| EU | Notified Bodies (per MDR) || USA | FDA-recognized accreditation bodies || MDSAP | Authorized auditing organizations || Global | ISO certification bodies (IATF, DNV, BSI, TÜV) |

tools-only/X-Skills/tree/main/content-creation/856-iso-regulatory-requirements_62c831f2 commit 30dc8bb0ea

Frequently asked questions

npx skillmds@latest add tools-only/iso-regulatory-requirements-for-medical-devices